(Health-NewsWire.Net, October 12, 2018 ) The global insulin delivery devices market is expected to reach US$ 22,830.0 Mn by 2025 from US$ 11,869.0 Mn in 2017. The market is estimated to grow with a CAGR of 8.7% during the forecast period from 2018 to 2025.
The global insulin delivery devices market is segmented into product, end user and geography. Based on product, the insulin delivery devices market is segmented into insulin pens, insulin pumps, insulin syringes, pen needles and others. The insulin pens segment is further bifurcated into reusable and disposable segments. The insulin pumps segment is also further segmented into tube pumps and patch pumps segments. On the basis of end user, the market is segmented into patients or home care and hospitals & clinics.
Request sample copy @ http://bit.ly/2yuHuqN
Insulin is an important treatment plan for the people suffering with diabetes that helps in getting glucose from bloodstream into the muscles and fat cells to be used for fuel. Insulin is injected or infused into the fatty tissue under the skin through the delivery devices. There are numerous devices that can be used to deliver insulin, including insulin pens, insulin pumps, pen needles, insulin syringes, and jet injectors among others. The report would be of an interest to various stakeholders operating in the insulin delivery devices. These stakeholders include healthcare institutes, pharmaceutical and biotechnology therapeutics manufactures and suppliers, academic and research institutes, insulin delivery devices manufacturers and vendors, distributors and others.
List of Companies mentioned in this study -
2. Novo Nordisk A/S
3. B. Braun Melsungen AG
4. Insulet Corporation
6. Tandem Diabetes Care, Inc.
7. Eli Lilly and Company
9. Owen Mumford, Ltd.
The objective of the study is to describe, define, and forecast the insulin delivery devices market by product end user, and region. The report also provide detailed information regarding the major factors influencing the growth of the market (drivers, restraints, opportunities, and trends). The report helps to analyze market with respect to individual growth trends, prospects, and contributions to the overall insulin delivery devices market.
The report analyzes factors affecting market from both demand and supply side and further evaluates insulin delivery devices market dynamics effecting the insulin delivery devices market during the forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors effecting the market in these regions. The report also includes the profiles of key manufacturing companies along with their SWOT analysis and market strategies.
The major players operating in the insulin delivery devices market include BD, B. Braun Melsungen AG, Insulet Corporation, Medtronic, Tandem Diabetes Care, Inc., Eli Lilly and Company, Biocon, Owen Mumford, Ltd., Sanofi and among others. The company players are indulged into development of novel and innovative products to cater the demands of the users in insulin delivery devices market. For instance, in June, 2018, Insulet Corporation received FDA approval for its Omnipod DASH Insulin Management System.
Inquire Before Buying @ http://bit.ly/2yreYWU
The Insight Partners